Interview with the Pharmacy of Australia The script is intended to be a guide only and the calls should take on a conversational manner. Thank you for agreeing to be interviewed for the MedsCheck program evaluation. Deloitte Access Economics is completing this evaluation on behalf of the Department of Health and Ageing. I expect this interview will take 30 minutes. The main purpose of this interview is to discuss the veracity of some of the findings from the MedsCheck evaluation. This will help ensure that they the findings have been correctly interpreted and that subsequently, key lessons are appropriately applied to the national Your input will help the Department to modify the MedsCheck program to make it more successful. The evaluation findings to date indicate that a majority of patients believe they were taking their medicines correctly as prescribed by their GP prior to their MedsCheck and that a lower proportion of patients than expected were identified by the pharmacist as taking one or more medicines incorrectly. The main benefit of the MedsCheck service for patients has been educational through an increased understanding of their medicines relating –realised to indication, dosing, side effects and storage. Taking the existing eligibility criteria into account, how do you believe the MedsCheck program could more effectively target the population likely to benefit? Do you believe that a more integrated approach between for example pharmacies and GP surgeries would help target patients more effectively or increase the scope of patient benefits? During interviews with pharmacists, a majority considered that the current payment model of $60 per MedsCheck and $90 per Diabetes MedsCheck is fair for a service which takes 30 – 60 minutes to complete. If the program is refined so that each service takes 30-60 minutes to complete, do you believe that the current payment is of a sufficient amount to encourage pharmacy businesses across Australia to provide regular services? (Please keep in mind the value of pharmacists performing other duties and the infrastructure requirements for service delivery). Keeping in mind the finite funds available for this program, do you believe that this payment model (i.e. fee for service, paid to the pharmacy) is appropriate? Other than payment, what other facilitators would encourage pharmacy businesses to take-up this program and pharmacists to subsequently deliver services?
Interview with the Pharmacy of Australia The script is intended to be a guide only and the calls should take on a conversational manner. Thank you for agreeing to be interviewed for the MedsCheck program evaluation. Deloitte Access Economics is completing this evaluation on behalf of the Department of Health and Ageing. I expect this interview will take 30 minutes. The main purpose of this interview is to discuss the veracity of some of the findings from the MedsCheck evaluation. This will help ensure that they the findings have been correctly interpreted and that subsequently, key lessons are appropriately applied to the national Your input will help the Department to modify the MedsCheck program to make it more successful. The evaluation findings to date indicate that a majority of patients believe they were taking their medicines correctly as prescribed by their GP prior to their MedsCheck and that a lower proportion of patients than expected were identified by the pharmacist as taking one or more medicines incorrectly. The main benefit of the MedsCheck service for patients has been educational –realised through an increased understanding of their medicines relating to indication, dosing, side effects and storage. Taking the existing eligibility criteria into account, how do you believe the MedsCheck program could more effectively target the population likely to benefit? Do you believe that a more integrated approach between for example pharmacies and GP surgeries would help target patients more effectively or increase the scope of patient benefits? During interviews with pharmacists, a majority considered that the current payment model of $60 per MedsCheck and $90 per Diabetes MedsCheck is fair for a service which takes 30 – 60 minutes to complete. If the program is refined so that each service takes 30-60 minutes to complete, do you believe that the current payment is of a sufficient amount to encourage pharmacy businesses across Australia to provide regular services? (Please keep in mind the value of pharmacists performing other duties and the infrastructure requirements for service delivery). Keeping in mind the finite funds available for this program, do you believe that this payment model (i.e. fee for service, paid to the pharmacy) is appropriate? Other than payment, what other facilitators would encourage pharmacy businesses to take-up this program and pharmacists to subsequently deliver services?